WaveMan
WaveMan · Company
HIT · Health In Tech, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

HIT Health In Tech (HIT) Insider Trading, Ownership & Congress Trades

Insurance · Insurance agents, brokers & service · CIK 0002019505
Quote by TradingView
Form 144 · 3
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
14
13F, latest reported quarter

What the filings say about HIT

Insiders, 180 days
-$39.8K net sold
2 sellers · 40% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$44.3K
3 notices

Health In Tech insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Health In Tech, Inc. insiders sold a net $39.8K of stock across 5 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-29.

Insider
Filed
Shares
Value
Since filing
Hasan Zain Syed
Chief Growth Officer
SELL
2026-10-19 SECtraded 2026-10-16
3,333
$2.1K
+2.0%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 11, 2026.
  • The trade is 1.9% of the 173,660 shares held after it.
  • No other insider sold within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Growth Officer Hasan Zain Syed sold about $2.1K of HIT under a 10b5-1 plan on Oct 16, 2026; 14 funds added in the latest 13F quarter.
Hayes Timothy
Director
SELL
2026-09-15 SECtraded 2026-09-14
12,000
$10.7K
-32.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Sep 11, 2026.
  • The trade is 11.0% of the 108,780 shares held after it.
  • 1 other insider sold within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hayes Timothy sold about $10.7K of HIT on Sep 14, 2026; 1 other insider sold within 30 days and 14 funds added in the latest 13F quarter.
Hayes Timothy
Director
SELL
2026-09-11 SEC
12,000
$10.9K
-35.3%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 9, 2026.
  • The trade is 9.9% of the 120,780 shares held after it.
  • 1 other insider sold within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hayes Timothy sold about $10.9K of HIT on Sep 11, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 14 funds added in the latest 13F quarter.
Hasan Zain Syed
Chief Growth Officer
SELL
2026-09-14 SECtraded 2026-09-11
11,667
$10.7K
-35.1%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 6.2% of the 188,544 shares held after it.
  • 1 other insider sold within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Growth Officer Hasan Zain Syed sold about $10.7K of HIT under a 10b5-1 plan on Sep 11, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 14 funds added in the latest 13F quarter.
Hayes Timothy
Director
SELL
2026-09-11 SECtraded 2026-09-09
5,730
$5.3K
-35.3%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 4.3% of the 132,780 shares held after it.
  • 1 other insider sold within 30 days.
  • 14 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Hayes Timothy sold about $5.3K of HIT on Sep 9, 2026, the largest insider sale at the company on our record; 1 other insider sold within 30 days and 14 funds added in the latest 13F quarter.
5 transactions on record · a thin record, read with care
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$39.8K over 180 days
-$39.8K over 90 days
more than 77% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
14 funds bought in last quarter
below 89% of Insurance
Revenue
+91.7% year over year
more than 95% of Insurance
Margin
3.4% net margin
below 72% of Insurance
Buybacks
no share repurchases reported
Short interest
3.5% of the float short (float per yahoo 2026-10-27) · 2.6 days to cover · settled 2026-10-15
What changed in the last 30 days
Oct 19Chief Growth Officer Hasan Zain Syed sold $2.1K under a 10b5-1 plan (Oct 16)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.

Watch HIT

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-80.4%12M
-82%-55%-27%+0%2025-102025-122026-022026-042026-062026-082026-10 2026-09-11 · Hayes Timothy sold $10.9K2026-09-11 · Hasan Zain Syed sold $10.7K2026-09-14 · Hayes Timothy sold $10.7K2026-09-09 · Hayes Timothy sold $5.3K2026-10-16 · Hasan Zain Syed sold $2.1K2026-09-14 · Hayes Timothy filed to sell $16.4K2026-09-14 · Hayes Timothy filed to sell $10.8K2026-09-10 · Hasan Zain Syed filed to sell $17.2K
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns HIT: institutional holders (13F)

13F holdings, latest reported quarter
Whetstone Capital Advisors, LLC
1,509,766 sh
$1.5M
Mink Brook Asset Management LLC
1,133,369 sh
$1.1M
VANGUARD CAPITAL MANAGEMENT LLC
568,475 sh
$574.2K
HEIGHTS CAPITAL MANAGEMENT, INC
350,268 sh
$353.8K
BlackRock, Inc.
349,595 sh
$353.1K

Congress trades in HIT

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

HIT planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Hayes Timothy
Filed 2026-09-14
$16.4K
Hayes Timothy
Filed 2026-09-14
$10.8K
Hasan Zain Syed
Filed 2026-09-10
$17.2K

HIT mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
iShares Micro-Cap ETF
$63.2K position · as of 2026-06-30
0.0%
1290 VT Micro Cap Portfolio
$3.9K position · as of 2026-06-30
0.0%
Fidelity Extended Market Index Fund
$77.6K position · as of 2026-05-31
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$161.1K position · as of 2026-06-30
0.0%
Fidelity Nasdaq Composite Index Fund
$33.4K position · as of 2026-05-31
0.0%
Fidelity Series Total Market Index Fund
$20.2K position · as of 2026-05-31
0.0%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $39.8K sold by insiders over 180 days, 14 funds added last quarter, $44.3K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLOSCRGL

HIT financials

Revenue growth
+91.7%
XBRL, annual
Net margin
3.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$36.0M
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-11.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
n/a
no debt line filed
Cash flow to debt
n/a
no debt line filed
Return on equity
-21.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-15.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-12
Revenue$37.6M$19.6M$19.2M
Gross profit$20.9M$15.4M$16.8M
Net income$1.3M$670.5K$4.0M
EPS (diluted)0.020.01n/a
Operating cash flow$3.1M$2.2M$1.5M
Cash$7.7M$7.8M$2.4M
SEC XBRL, fiscal years, as known on 2026-10-29

HIT Stock Sonar score 5/7 axes

Find similar shapesCompare

HIT ranks highest on growth (95th percentile) and risk and compliance (74th), and lowest on profitability (6th), among Insurance peers.

ProfitGrowthInsidersInstitutionsRisk
Profitability
6
Inputs
  • Return on equity-21.9% · 7 pct, sector of 116
  • Return on assets-15.2% · 6 pct, sector of 122
  • Return on invested capitalfewer than four consecutive quarters of operating income
  • Return on capital employedfewer than four consecutive quarters of operating income
Growth
95
Inputs
  • Revenue growth, YoY+91.7% · 95 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
38
Inputs
  • Net Form 4 buying (codes P and S), 180d-$27K · 77 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
11
Inputs
  • Funds adding, latest quarter14 · 11 pct, sector of 108
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
74
Inputs
  • Short interest, % of float+3.5% · 49 pct, sector of 138
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-K+0.3% · 100 pct, sector of 110
2 not measured: Financial health, US patents
  • Financial health needs 1 of 2 inputs, 0 present: no debt line filed
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

HIT filings, in plain words

Are Health In Tech insiders buying or selling HIT?

In the 180 days to 2026-10-29, Health In Tech insiders were net sellers, a net $39.8K across purchases and sales reported on Form 4, by 2 sellers.

Are there planned insider sales of HIT?

Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-29, covering $44.3K of stock; the latest, by Hayes Timothy, was filed 2026-09-14.

Read the full summary

In the 180 days to 2026-10-29, Health In Tech insiders were net sellers of HIT, a net $39.8K across purchases and sales reported on Form 4 by 2 sellers. 40% of the 5 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-29, covering $44.3K of stock. Each figure is counted from SEC and House filings as of 2026-10-29, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies